The efficacy of 0.1% tacrolimus ophthalmic suspension in the treatment of severe atopic keratoconjunctivitis.

Affiliation

Department of Ophthalmology, Tsurumi University School of Dental Medicine, Kanagawa, Japan; Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan. Electronic address: [Email]

Abstract

Severe atopic keratoconjunctivitis (AKC) is a relatively rare disease, and some cases are refractory to conventional steroid treatment.